AbbVie Inc. (ABBV) Stock

AbbVie Inc. (ABBV) is a Healthcare stock trading at $216.50 (as of 2026-06-18), with a market capitalization of $383.62B and a trailing P/E of 112.2. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

I can’t produce a description that follows your rules because the company’s SEC 10-K “Business” (Item 1) text wasn’t provided. Paste the AbbVie 10-K Item 1 section, and I’ll summarize it in 1–2 sentences (~45 words) based only on those facts.

Valuation — source: SEC EDGAR (first-party)
Price$216.50
Market Cap$383.62B
P/E Ratio112.2
EV / EBITDA28.4
Price / Book-60.85
Price / Sales6.40
Dividend Yield2.9%
DCF Value (model)$105.00
DCF Upside vs Price-51.5%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$61.16B
Net Margin6.9%
Return on Equity-55.0%
Debt / Equity-9.76
Current Ratio0.80
Revenue Growth (YoY)12.4%
EPS Growth (YoY)-45.8%
FCF Growth (YoY)154.6%
Financial Health — source: SEC EDGAR
Altman Z-Score2.21 (grey)
Piotroski F-Score6/9 (moderate)
Valuation vs Sector & Industry
Stock P/E112.2
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector435.2%
vs Industry549.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Insider Sells (12mo)2
Top Institutional HolderVANGUARD GROUP INC ($41.31B)
Institutional Holders Tracked10
Congressional Trades (recent)10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEORobert A. Michael
Employees55,000
CountryUS
IPO Date2013-03-15

Related Companies (Business model: Big Pharma / Branded Drugs; 8 closest by market cap; US-domiciled)

  • Eli Lilly and Company (LLY)
  • Johnson & Johnson (JNJ)
  • Merck & Co., Inc. (MRK)
  • Abbott Laboratories (ABT)
  • Amgen Inc. (AMGN)
  • Gilead Sciences, Inc. (GILD)
  • Pfizer Inc. (PFE)
  • Bristol-Myers Squibb Company (BMY)
ABBV earnings history · ABBV institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.